Table 2.
Seroprevalence of AIV in sub-Saharan Africa.
| Study Regions | No. of Studies | No. of Samples | No. Samples | Seroprevalence (%) |
|---|---|---|---|---|
| Central Africa a | 0 | - | - | - |
| East Africa b | 2 | 3517 | 77 | 2.2 |
| West Africa c | 11 | 16,669 | 875 | 5.2 |
| Southern Africa d | 4 | 235,084 | 9605 | 4.1 |
| Total | 18 | 255,270 | 10,557 | Overall seroprevalence: 4.1 |
Study regions: a Central African Republic, Congo Brazzaville, Cameroon and Democratic Republic of Congo, b Kenya, Uganda, c Benin, Burkina Faso, Ivory Coast, Gabon, Ghana, Mali, Niger, Nigeria, Togo, d Botswana, Namibia, South Africa, Zambia, Zimbabwe.